Drug intelligence / Profile preview

Lute-gen

Development stage: Preclinical
Lead developer: Bio-gen Extracts
Administration: Oral

Overview

Lute-gen is a branded nutraceutical complex composed of the macular xanthophyll carotenoids lutein and zeaxanthin, derived from marigold (Tagetes erecta) flowers. Developed by Bio-gen Extracts, it is designed to enhance macular pigment optical density (MPOD), which serves as a natural filter for high-energy blue light and provides antioxidant protection against photo-oxidative damage in the retina. Beyond ocular health, Lute-gen is being investigated for its role in the eye-brain axis to support cognitive functions such as memory, attention, and processing speed. It is currently being evaluated in clinical trials, including studies on digital eye strain and cognitive performance in teenagers.

Brand names: Lute-gen
Other names: Lute-gen LZlutein + zeaxanthin

Beyond the preview

Go deeper on Lute-gen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lute-gen.

Explore the full profile